- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02291120
MEDCEM PC and MTA in Pulpotomies of Primary Molars
November 11, 2014 updated by: Cristina Cuadros, Universitat Internacional de Catalunya
The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MEDCEM PC and MTA when used as pulp dressings following pulpotomy in human primary molars.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Sant Cugat del Valles, Barcelona, Spain, 08195
- Recruiting
- Universitat Internacional de Catalunya
-
Contact:
- Cristina Cuadros Fernandez, DDS, MsC
- Phone Number: 0034 93 5045000
- Email: cuadros@uic.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy children
- molars showing: symptomless exposure of vital pulp by caries no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) the possibility of proper restoration of the teeth no physiological resorption of more than one-third of the root
Exclusion Criteria:
- presence of systemic pathology
- history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: MTA
ProRoot® MTA is a root canal repair material that is a unique improvement over other materials used for root canal repair.
Made up of fine hydrophilic particles that set in the presence of water, ProRoot® MTA seals off all pathways between the root canal system and surrounding tissues, significantly reducing bacterial migration.
Its excellent compatibility with the dentinal wall allows for a predictable clinical healing response.
|
|
Experimental: MedCem Portland Cement (PC)
MedCem PC is an excellent capping material for cariology on permanent teeth (direct and indirect capping) and in milk tooth endodontics (milk tooth amputation).
Is characterized by excellent colour stability and neutrality and does not contain any additional ingredients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical success
Time Frame: 24 months
|
No pain, no swelling, no fistula or sinus tract, no pathologic mobility
|
24 months
|
Radiographic success
Time Frame: 24 months
|
No internal root resorption progressing into the bone, no external root resorption, no furcation and/or periapical bone destruction
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Anticipated)
October 1, 2015
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
June 27, 2014
First Submitted That Met QC Criteria
November 11, 2014
First Posted (Estimate)
November 14, 2014
Study Record Updates
Last Update Posted (Estimate)
November 14, 2014
Last Update Submitted That Met QC Criteria
November 11, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- UIC-ODP-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.
-
Hadassah Medical OrganizationCompletedPulpotomies Primary Teeth | Effectiveness of MedCem MTA® in Pulpotomies Primary TeethIsrael
-
Mayo ClinicCompletedEvaluate the Role of Real-time Imaging in Needle Placement | Evaluate the Workflow and Effectiveness of Realtime Imaging Versus Standard MR ImagingUnited States
-
Chun PanUnknownEvaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.China
-
Hadassah Medical OrganizationCompletedTo Evaluate Effectiveness of the Gait Trainer in Increasing the Functionality and Spatiotemporal Parameters of Gait of 4 Patients.Israel
-
Ain Shams UniversityUnknownTo Evaluate the Impact of the Vaginal Ph and Acidification of Vaginal Misoprostol on Its Efficacy in Facilitating Induction of Mid-trimester Abortion.United States
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingTo Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Jinan University; First Affiliated Hospital of... and other collaboratorsRecruitingEvaluate the Efficacy of Cyclical Topical Wound Oxygen Therapy in the Treatment of Chronic WoundsChina
-
CerbaXpertRecruitingEvaluate the Physiological Stability of NIS4 Biomarker Between the Fed and Fasting State in Patients With the Target Condition (NAFLD)France
-
Tomey CorporationCompletedEvaluate the Agreement and Precision of Device SS-1000 and the Predicate Device the Pentacam in a Reproducibility and Repeatability TrialJapan
-
Chang Bing Show Chwan Memorial HospitalCompletedEvaluate the Effects of an Oral Health Promotion Program
Clinical Trials on Pulpotomy
-
University GhentCompleted
-
Cairo UniversityNot yet recruiting
-
Postgraduate Institute of Dental Sciences RohtakRecruitingPulpitis - IrreversibleIndia
-
Cairo UniversityUnknownSymptomatic Irreversible Pulpitis
-
British University In EgyptAin Shams UniversityRecruiting
-
University of Alabama at BirminghamNot yet recruitingIrreversible PulpitisUnited States
-
Jordan University of Science and TechnologyActive, not recruiting
-
National University Health System, SingaporeCompletedPulpitis | Pulp Exposure, Dental | Pulp and Periapical Tissue Disease
-
Shahid Beheshti University of Medical SciencesIranian center for endodontic researchUnknownPulpotomy TreatmentIran, Islamic Republic of